09:13 AM EST, 11/08/2024 (MT Newswires) -- Maravai Lifesciences ( MRVI ) said late Thursday it has agreed to buy Officinae Bio's DNA and RNA business.
This acquisition will support Maravai Lifesciences ( MRVI ) and its TriLink BioTechnologies unit's customers in developing new nucleic acid-based therapies, Maravai Bio said.
Financial terms were not disclosed for the deal, which is slated to be completed early next year.